洪田股份(603800.SH):全資子公司擬1000萬元參與認購股權投資基金
格隆匯3月12日丨洪田股份(603800.SH)公佈,近日,公司全資子公司萊維投資與廈門縱橫金鼎私募基金管理有限公司(以下簡稱“管理人”“縱橫金鼎”)簽訂了《共青城畢方創業投資合夥企業(有限合夥)合夥協議》(以下簡稱:“合夥協議”)及《共青城畢方創業投資合夥企業(有限合夥)合夥協議之補充協議》(以下簡稱:“補充協議”),在確保滿足日常經營資金需求、總體投資風險可控的前提下,爲了進一步拓展投資領域,充分利用專業機構的經驗和資源,萊維投資作爲有限合夥人以自有資金人民幣1,000萬元出資認購基金份額。縱橫金鼎爲基金的普通合夥人,同時也爲基金的管理人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.